OpenBilldrug price receipt

NADAC week of 2026-10-14

MEMANTINE HCL ER 28 MG CAPSULE

For 30 capsules

Pharmacies pay

$10.27 filed

30 × $0.34223 per EA

CMS NADAC · nadac-national-average-drug-acquisition-cost-20261014.csv · eff. 2026-09-23 · as of 2026-10-14 · retrieved 2026-10-17

Medicare Part D paid

$68.12 filed

30 × $2.27078 per EA, Part D average

Medicare's price is not your price.

Medicare Part D · DSD_PTD_RY26_P04_V10_DY24_BGM.csv · eff. 2024-01-01 to 2024-12-31 · as of 2026-06-25 · retrieved 2026-10-18


The spread

6.6× estimated

Medicare paid 6.6× what pharmacies pay.

Part D averages every strength and form sold under “Memantine HCl ER” / “Memantine HCl” into one figure, so it is not specific to this NDC.

OpenBill calculation · DSD_PTD_RY26_P04_V10_DY24_BGM.csv + nadac-national-average-drug-acquisition-cost-20261014.csv · NADAC eff. 2026-09-23 (file of 2026-10-14, retrieved 2026-10-17) · Part D 2024-01-01 to 2024-12-31 (file of 2026-06-25, retrieved 2026-10-18)

Cost-plus estimate

$16.81 estimated

$10.27 + $1.54 (15%) + $5.00 fee per fill = $16.81

This is a model, not a price any pharmacy quoted. Shipping is not included. How it is worked out

OpenBill calculation · nadac-national-average-drug-acquisition-cost-20261014.csv · NADAC eff. 2026-09-23 (file of 2026-10-14, retrieved 2026-10-17)

Open the interactive card Change the quantity, type what you were charged, and see every record in full.

What it is

MEMANTINE HCL ER 28 MG CAPSULE is how the CMS NADAC file names this product. The FDA NDC Directory lists it as “memantine hydrochloride” and “memantine”, as its NDCs’ listings variously write the nonproprietary name.

FDA gives its dosage form as capsule, extended release and its route as oral.

FDA lists 7 labelers (the companies named on the label) for its NDCs, among them Rising Pharma Holdings, Inc., Aurobindo Pharma Limited and Amneal Pharmaceuticals LLC.

FDA’s Established Pharmacologic Class for it is N-methyl-D-aspartate Receptor Antagonist.

The NADAC file of 2026-10-14 prices it under 13 NDCs (National Drug Codes).

NADAC classes it as a generic drug (rate-setting class G), and does not mark it as sold over the counter.

What pharmacies pay

Pharmacies pay $10.27 for 30 capsules (30 × $0.34223 per EA, rounded to the cent), by the CMS NADAC file of 2026-10-14; that price took effect on 2026-09-23. That is what pharmacies pay their suppliers, not what they charge you.

NADAC’s explanation code for it: 1, calculated from the most recently completed pharmacy survey.

The 7 labelers

LabelerNDCsPharmacies pay per unit
Amneal Pharmaceuticals LLC2$0.34223 per EA filed
Aurobindo Pharma Limited2$0.34223 per EA filed
Lupin Pharmaceuticals, Inc.2$0.34223 per EA filed
Rising Pharma Holdings, Inc.2$0.34223 per EA filed
Slate Run Pharmaceuticals, LLC2$0.34223 per EA filed
Zydus Pharmaceuticals USA Inc.2$0.34223 per EA filed
Vitruvias Therapeutics, Inc.1$0.34223 per EA filed
All 13 NDCs, with labeler and price
  • 16571-0855-03 · Rising Pharma Holdings, Inc. · $0.34223 per EA · eff. 2026-09-23 filed
  • 16571-0855-09 · Rising Pharma Holdings, Inc. · $0.34223 per EA · eff. 2026-09-23 filed
  • 59651-0407-30 · Aurobindo Pharma Limited · $0.34223 per EA · eff. 2026-09-23 filed
  • 59651-0407-90 · Aurobindo Pharma Limited · $0.34223 per EA · eff. 2026-09-23 filed
  • 65162-0785-03 · Amneal Pharmaceuticals LLC · $0.34223 per EA · eff. 2026-09-23 filed
  • 65162-0785-09 · Amneal Pharmaceuticals LLC · $0.34223 per EA · eff. 2026-09-23 filed
  • 68180-0249-06 · Lupin Pharmaceuticals, Inc. · $0.34223 per EA · eff. 2026-09-23 filed
  • 68180-0249-09 · Lupin Pharmaceuticals, Inc. · $0.34223 per EA · eff. 2026-09-23 filed
  • 68382-0549-06 · Zydus Pharmaceuticals USA Inc. · $0.34223 per EA · eff. 2026-09-23 filed
  • 68382-0549-16 · Zydus Pharmaceuticals USA Inc. · $0.34223 per EA · eff. 2026-09-23 filed
  • 69680-0164-30 · Vitruvias Therapeutics, Inc. · $0.34223 per EA · eff. 2026-09-23 filed
  • 70436-0057-04 · Slate Run Pharmaceuticals, LLC · $0.34223 per EA · eff. 2026-09-23 filed
  • 70436-0057-06 · Slate Run Pharmaceuticals, LLC · $0.34223 per EA · eff. 2026-09-23 filed

Other strengths, forms and brands

7 other products in the NADAC file share an FDA nonproprietary name with MEMANTINE HCL ER 28 MG CAPSULE.

ProductPharmacies pay per unitMedicare per unit
MEMANTINE 5-10 MG TITRATION PK
generic · kit
$0.37236 per EA filed
eff. 2025-10-22
$0.40251 per EA filed
Part D 2024 average
MEMANTINE HCL 2 MG/ML SOLUTION
generic · solution
$0.36068 to $0.8106 per ML filed
eff. 2026-07-22 to 2026-09-23
We don’t know yet
MEMANTINE HCL 5 MG TABLET
generic · tablet / tablet, film coated
$0.07926 per EA filed
eff. 2026-09-23
$0.40251 per EA filed
Part D 2024 average
MEMANTINE HCL 10 MG TABLET
generic · tablet / tablet, film coated
$0.063 per EA filed
eff. 2026-09-23
$0.40251 per EA filed
Part D 2024 average
MEMANTINE HCL ER 7 MG CAPSULE
generic · capsule, extended release
$0.31233 per EA filed
eff. 2026-09-23
$2.27078 per EA filed
Part D 2024 average
MEMANTINE HCL ER 14 MG CAPSULE
generic · capsule, extended release
$0.34512 per EA filed
eff. 2026-09-23
$2.27078 per EA filed
Part D 2024 average
MEMANTINE HCL ER 21 MG CAPSULE
generic · capsule, extended release
$0.35626 per EA filed
eff. 2026-09-23
$2.27078 per EA filed
Part D 2024 average
MEMANTINE HCL ER 28 MG CAPSULE this page
generic · capsule, extended release
$0.34223 per EA filed
eff. 2026-09-23
$2.27078 per EA filed
Part D 2024 average

Part D is one average per brand and generic name, over every strength and form.

CMS NADAC · nadac-national-average-drug-acquisition-cost-20261014.csv · eff. 2025-10-22, 2026-07-22, 2026-09-23 · as of 2026-10-14 · retrieved 2026-10-17

Medicare Part D · DSD_PTD_RY26_P04_V10_DY24_BGM.csv · eff. 2024-01-01 to 2024-12-31 · as of 2026-06-25 · retrieved 2026-10-18

Compared with its class

The middle of its 13 NDCs’ NADAC prices is $0.34223 per EA filed.

Of the 11 other products in FDA’s N-methyl-D-aspartate Receptor Antagonist class priced per EA, 8 have a higher middle NADAC price and 3 a lower one. The one in the middle is MEMANTINE-DONEPEZIL ER 14-10 MG, at $6.48822 per EA filed (eff. 2026-09-23).

Prices are compared per unit, whatever the strength or dose, and a class is not a list of substitutes.

CMS NADAC · nadac-national-average-drug-acquisition-cost-20261014.csv · eff. 2026-09-23 · as of 2026-10-14 · retrieved 2026-10-17

What Medicare paid

Medicare Part D paid $68.12 for 30 capsules, at an average of $2.27078 per EA in 2024 (2024-01-01 to 2024-12-31) for “Memantine HCl ER” and “Memantine HCl”, every strength and form sold under that name together (Medicare Part D Spending by Drug, file of 2026-06-25).

That average covers 650,504 Part D claims (fills, including refills) for 2024-01-01 to 2024-12-31, across every maker, strength and form under the name.

Medicare's price is not your price.

What to ask at the counter

None of these figures is your price: what you pay depends on your pharmacy, your insurance, coupons and discounts.

Questions

Why is the comparison with Medicare for MEMANTINE HCL ER 28 MG CAPSULE labelled estimated?
Beyond what the card shows, the records give these reasons: The Part D figure covers 2024-01-01 to 2024-12-31; the NADAC price is from the file of 2026-10-14. Part D spending basis, as the Part D record states it: Part D 2024 average spend per dosage unit for Memantine HCl ER / Memantine HCl: all makers, strengths, forms and routes combined, claim-weighted; gross cost incl. dispensing fees and patient pay, before rebates. Unit taken as NADAC's EA. Joined on generic name.